Arterial ischemic stroke in childhood: Risk factors and outcome in old versus new era

Journal of Child Neurology

Volumn 22, Issue 10, 2007, Pages 1204-1208

  Gökben, Sarenur ^a   Tosun, Ayse ^a   Bayram, Nuri ^a   Serdaroglu, Gul ^a   Polat, Muzaffer ^a   Kavakli, Kaan ^a   Tekgul, Hasan ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Childhood ischemic stroke; Outcome; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; CARDIOLIPIN ANTIBODY; HOMOCYSTEINE; LIPOPROTEIN; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; PROTEIN C; PROTEIN S; PROTHROMBIN; WARFARIN; ANTIBODY; BIOLOGICAL MARKER; PLASMA PROTEIN;

ADOLESCENT; ARTICLE; BLOOD CLOTTING DISORDER; CEREBROVASCULAR ACCIDENT; CHILD; CHILD HEALTH; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GENE MUTATION; HUMAN; INFANT; INTERMETHOD COMPARISON; MALE; MOYAMOYA DISEASE; OUTCOME ASSESSMENT; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; BLOOD; BLOOD ANALYSIS; BRAIN ISCHEMIA; INCIDENCE; PREDICTION AND FORECASTING; PRESCHOOL CHILD; RECURRENT DISEASE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STROKE; TURKEY (REPUBLIC);

ADOLESCENT; ANTIBODIES; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; BLOOD COAGULATION DISORDERS; BLOOD PROTEINS; BRAIN ISCHEMIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; PREDICTIVE VALUE OF TESTS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STROKE; TURKEY;

EID: 38149007000     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073807307863     Document Type: Article

References (37)

1. Pavlakis SG, Gould RJ, Zito JL Stroke in children. Adv Pediatr. 1991; 38:151-179.
2. Kirkham FJ Stroke in Childhood. Arch Dis Child. 1999; 81:85-89.
3. Eeg-Olofsson O., Ringheim Y. Stroke in children. Clinical characteristics and prognosis. Acta Paediatr Scand. 1983; 72:391-395.
4. Kittner SJ, Adams RJ Stroke in children and young adults. Curr Opin Neurol. 1996; 9:53-56.
5. Lynch JK, Hirtz DG, DeVeber G., Nelson KB Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics. 2002; 109:116-123.
6. Schoenberg BS, Mellinger JF, Schoenberg DG Cerebrovascular disease in infants and children: A study of incidence, clinical features, and survival. Neurology 1978; 28:763-768.
7. Nicolaides P., Appleton RE Stroke in children. Dev Med Child Neurol. 1996; 38:172-180.
8. Roach ES Etiology of stroke in children. Semin Pediatr Neurol. 2000; 7:244-260.
9. deVeber G., Roach ES, Riela AR, Wiznitzer M. Stroke in children: recognition, treatment, and future directions. Semin Pediatr Neurol. 2000; 7:309-317.
10. Gadian DG, Calamante F., Kirkham FJ, et al. Diffusion and perfusion magnetic resonance imaging in childhood stroke. J Child Neurol. 2000; 15:279-283.
11. Broderick JP, Narayan S., Gaskill M., Dhawan AP, Khoury J. Volumetric measurement of multifocal brain lesions. Implications for treatment trials of vascular dementia and multiple sclerosis. J Neuroimaging. 1996; 6:36-43.
12. Shirane R., Sato S., Yoshimoto T. Angiographic findings of ischemic stroke in children. Childs Nerv Syst. 1992; 8:432-436.
13. Chabrier S., Rodesch G., Lasjaunias P., Tardieu M., Landrieu P., Sebire G. Transient cerebral arteriopathy: A disorder recognized by serial angiograms in children with stroke. J Child Neurol. 1998; 13:27-32.
14. Ganesan V., Savvy L., Chong WK, Kirkham FJ Conventional cerebral angiography in children with ischemic stroke. Pediatr Neurol. 1999; 20:38-42.
15. Chan A.K., deVeber G. Prothrombotic disorders and ischemic stroke in children. Semin Pediatr Neurol. 2000; 7:301-308.
16. Akar N., Gokdemir R., Ozel D., Akar E. Endothelial cell protein C receptor (EPCR) gene exon III, 23 bp insertion mutation in the Turkish pediatric thrombotic patients. Thromb Haemost. 2002; 88:1068-1069.
17. deVeber G., Monagle P., Chan A., et al. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol. 1998; 55:1539-1543.
18. Manco-Johnson MJ, Nuss R., Key N., et all. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr. 1996; 128:319-323.
19. Ganesan V., Kelsey H., Cookson J., Osborn A., Kirkham FJ Activated protein C resistance in childhood stroke. Lancet. 1996; 347:260.
20. Bonduel M., Sciuccati G., Hepner M., Torres AF, Pieroni G., Frontroth JP Prothrombotic disorders in children with arterial ischemic stroke and sinovenous thrombosis. Arch Neurol. 1999; 56:967-971.
21. Kenet G., Sadetzki S., Murad H., Martinowitz U., Rosenberg N., Gitel S., et al: Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke. 2000; 31:1283-1288.
22. Bonduel M., Hepner M., Sciuccati G., Torres AF, Tenembaum S. Prothrombotic disorders in children with moyamoya syndrome. Stroke. 2001; 32:1786-1792.
23. Heller C., Becker S., Scharrer I., Kreuz W. Prothrombotic risk factors in childhood stroke and venous thrombosis. Eur J Pediatr. 1999; 158:117-121.
24. Lanska MJ, Lanska DJ, Horwitz SJ, Aram DM Presentation, clinical course, and outcome of childhood stroke. Pediatr Neurol. 1991; 7:333-341.
25. Chabrier S., Husson B., Lasjaunias P., Landrieu P., Tardieu M. Stroke in childhood: Outcome and recurrence risk by mechanism in 59 patients. J Child Neurol. 2000; 15:290-294.
26. Lanthier S., Carmant L., David M., Larbrisseau A., de Veber G. Stroke in children: The coexistence of multiple risk factors predicts poor outcome. Neurology. 2000; 54:371-378.
27. Sreenan C., Bhargava R., Robertson CM Cerebral infarction in the term newborn: Clinical presentation and long-term outcome. J Pediatr. 2000; 137:351-355.
28. Landau WM, Nassief A. Time to burn the TOAST. Stroke. 2005; 902-905.
29. Hunter JV New radiographic techniques to evaluate cerebrovascular disorders in children. Semin Pediatr Neurol. 2000; 7:261-277.
30. de Veber GA, Adams M., Andrew M., and Canadian Pediatric Neurologist. Canadian Pediatric Ischemic Stroke Registry. Can J Neurol Sci. 1995; 22(S1):S24.
31. Akar N. Molecular approach to Turkish pediatric stroke patients. Turk J Haematol. 2002; 19:245-253.
32. Gürgey A., Mesci L. The prevalence of factor V Leiden (1691 G-A) mutation in Turkey. Turk J Pediatr. 1997; 39:313-315.
33. Akar N., Akar E., Dalgιn G., Sözüöz A., Ömürlü K., Cin S. Frequency of factor V 1691(G-A) mutation in Turkish population. Thromb Haemost. 1997; 78:1527-1528.
34. Press RD, Liu XY, Beamer N., Coull BM Ischemic stroke in the elderly. Role of the common factor V mutation causing resistance to activated protein Stroke. 1996; 27:44-48.
35. Longstreth WT Jr, Rosendaal FR, Siscovick DS, et al. Risk of stroke in young women and two prothrombotic mutations: Factor V Leiden and prothrombin gene variant (G20210A) Stroke. 1998; 29:577-580.
36. Angelini L., Ravelli A., Caporali R., Rumi V., Nardocci N., Martini A. High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia. Pediatrics. 1994; 94:500-503.
37. Cupido C., deVeber G., Adams M. Canadian Pediatric Ischemic Stroke Study Group. A prospective clinical study of congenital heart disease in pediatric stroke [Abstract]. Ann Neurol. 1996; 40:48.